The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Liver-targeted disruption of Apc in mice activates β-catenin signaling and leads to hepatocellular carcinomas
Open accessAbstract
Although inappropriate activation of the Wnt/β-catenin pathway has been implicated in the development of hepatocellular carcinoma (HCC), the role of this signaling in liver carcinogenesis remains unclear. To investigate this issue, we constructed a mutant mouse strain,Apclox/lox, in which exon 14 of the tumor-suppressor gene adenomatous polyposis coli (Apc) is flanked by loxP sequences. i.v. injection of adenovirus encoding Cre recombinase (AdCre) at high multiplicity [10 9 plaque-forming units (pfu) per mouse] inactivated the Apc gene in the liver and resulted in marked hepatomegaly, hepatocyte hyperplasia, and rapid mortality. β-Catenin signaling activation was demonstrated by nuclear and cytoplasmic accumulation of β-catenin in the hepatocytes and by the induction of β-catenin target genes (glutamine synthetase, glutamate transporter 1, ornithine aminotransferase, and leukocyte cell-derived chemotaxin 2) in the liver. To test a long-term oncogenic effect, we inoculated mice with lower doses of AdCre (0.5 × 10 9 pfu per mouse), compatible with both survival and persistence of β-catenin-activated cells. In these conditions, 67% of mice developed HCC. β-Catenin signaling was strongly activated in these Apc-inactivated HCCs. The HCCs were well, moderately, or poorly differentiated. Indeed, their histological and molecular features mimicked human HCC. Thus, deletion of Apc in the liver provides a valuable model of human HCC, and, in this model, activation of the Wnt/β-catenin pathway by invalidation of Apc is required for liver tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
Caught up in a Wnt storm: Wnt signaling in cancer
Giles, R. H., van Es, J. H., & Clevers, H. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00005-2 · Cited by 1,482
Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M.-A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8847 · Cited by 1,121
Self-citationHepatocellular carcinoma: Diagnosis and treatment
Befeler, A. S., & di Bisceglie, A. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.33411 · Cited by 602
Laurent–Puig, P., Legoix, P., Bluteau, O., Belghiti, J., Franco, D., Binot, F., Monges, G., Thomas, G., Bioulac–Sage, P., & Zucman–Rossi, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.24798 · Cited by 582
New targets of β-catenin signaling in the liver are involved in the glutamine metabolism
Cadoret, A., Ovejero, C., Terris, B., Souil, E., Lévy, L., Lamers, W. H., Kitajewski, J., Kahn, A., & Perret, C. (2002) · Oncogene · doi:10.1038/sj.onc.1206118 · Cited by 410
Self-citationThe p53 Tumor Suppressor Gene: From Molecular Biology to Clinical Investigation
SOUSSI, T. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06705.x · Cited by 332
Genetics of hepatocellular carcinoma
Annick Buendia, M. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0319 · Cited by 329
Yang, Y., Xiang, Z., Ertl, H. C., & Wilson, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7257 · Cited by 260
Risk of hepatoblastoma in familial adenomatous polyposis
Giardiello, F. M., Offerhaus, G. J. A., Krush, A. J., Booker, S. V., Tersmette, A. C., Mulder, J.-W. R., Kelley, C. N., & Hamilton, S. R. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80297-5 · Cited by 255
Colnot, S., Niwa-Kawakita, M., Hamard, G., Godard, C., Le Plenier, S., Houbron, C., Romagnolo, B., Berrebi, D., Giovannini, M., & Perret, C. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700180 · Cited by 196
Self-citationHepatocarcinogenesis in Mice with β-Catenin and Ha-Ras Gene Mutations
Harada, N., Oshima, H., Katoh, M., Tamai, Y., Oshima, M., & Taketo, M. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2123 · Cited by 194
Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.
Cadoret, A., Ovejero, C., Saadi-Kheddouci, S., Souil, E., Fabrè, M., Romagnolo, B., Kahn, A., & Perret, C. (2001) · PubMed · Cited by 169
Self-citationRisk of hepatoblastoma in familial adenomatous polyposis
Hughes, L. J., & Michels, V. V. (1992) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320430621 · Cited by 166
Harada, N., Miyoshi, H., Murai, N., Oshima, H., Tamai, Y., Oshima, M., & Taketo, M. M. (2002) · PubMed · Cited by 164
Aydinlik, H., Nguyen, T. D., Moennikes, O., Buchmann, A., & Schwarz, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204982 · Cited by 164
Legoix, P., Bluteau, O., Bayer, J., Perret, C., Balabaud, C., Belghiti, J., Franco, D., Thomas, G., Laurent-Puig, P., & Zucman-Rossi, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202800 · Cited by 162
Self-citationBuchmann, A., Bauer-Hofmann, R., Mahr, J., Drinkwater, N. R., Luz, A., & Schwarz, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.911 · Cited by 159
Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene.
Wang, Y., Krushel, L. A., & Edelman, G. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3932 · Cited by 158
Mutation of β-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis
Devereux, T. R., Anna, C. H., Foley, J. F., White, C. M., Sills, R. C., & Barrett, J. C. (1999) · Oncogene · doi:10.1038/sj.onc.1202858 · Cited by 123
Biallelic inactivation of the APC gene in hepatoblastoma.
Kurahashi, H., Takami, K., Oue, T., Kusafuka, T., Okada, A., Tawa, A., Okada, S., & Nishisho, I. (1995) · PubMed · Cited by 120
Ovejero, C., Cavard, C., Périanin, A., Hakvoort, T., Vermeulen, J., Godard, C., Fabre, M., Chafey, P., Suzuki, K., Romagnolo, B., et al. (2004) · Hepatology · doi:10.1002/hep.20286 · Cited by 118
Self-citationRomagnolo, B., Berrebi, D. D., Saadi-Keddoucci, S., Porteu, A., Pichard, A., Peuchmaur, M. M., Vandewalle, A., Kahn, A., & Perret, C. (1999) · PubMed · Cited by 118
Self-citationPrange, W., Breuhahn, K., Fischer, F. F., Zilkens, C., Pietsch, T., Petmecky, K., Eilers, R., Dienes, H., & Schirmacher, P. (2003) · The Journal of Pathology · doi:10.1002/path.1448 · Cited by 112
Cui, J., Zhou, X., Liu, Y., Tang, Z., & Romeih, M. H. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02973.x · Cited by 109
Calvisi, D. F., Factor, V. M., Ladu, S., Conner, E. A., & Thorgeirsson, S. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.014 · Cited by 100
Gotoh, J., Obata, M., Yoshie, M., Kasai, S., & Ogawa, K. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.435 · Cited by 85
BRCA1: the enigma of tissue-specific tumor development
Monteiro, Á. N. A. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00110-0 · Cited by 75
Gruner, B. A., DeNapoli, T. S., Andrews, W. S., Tomlinson, G. E., Bowman, L. C., & Weitman, S. D. (1998) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199805000-00018 · Cited by 70
The multiple functions of tumour suppressors: it's all in APC
Fodde, R. (2003) · Nature Cell Biology · doi:10.1038/ncb0303-190 · Cited by 66
Leneuve, P., Colnot, S., Hamard, G., Francis, F., Niwa-Kawakita, M., Giovannini, M., & Holzenberger, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng021 · Cited by 65
Self-citationAnna, C. H., Iida, M., Sills, R. C., & Devereux, T. R. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00170-4 · Cited by 62
Su, L.-K., Abdalla, E. K., Law, C., Kohlmann, W., Rashid, A., & Vauthey, J. (2001) · Cancer · Cited by 42
Nakano, A. (2003) · Hepatology Research · doi:10.1016/s1386-6346(02)00207-3 · Cited by 26
Cited by
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“Around one third of HCCs have activation of the Wnt signaling pathway (particularly HCVrelated HCCs), as a result of activating mutations in the transcription factor ß-catenin [175,317,318], overexpression of Frizzled receptors or inactivation of E-cadherin or members of the degradation complex (GSK3B, AXIN, adenomato…”
BackgroundTGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Tauriello, D. V. F., Palomo-Ponce, S., Stork, D., Berenguer-Llergo, A., Badia-Ramentol, J., Iglesias, M., Sevillano, M., Ibiza, S., Cañellas, A., Hernando-Momblona, X., et al. (2018) · Nature · doi:10.1038/nature25492 · Cited by 1,851
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
(2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.021 · Cited by 1,096
Metadata
- Authors
- Colnot, S., Decaens, T., Niwa-Kawakita, M., Godard, C., Hamard, G., Kahn, A., Giovannini, M., & Perret, C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-11-24
- Volume
- 101
- Issue
- 49
- Pages
- 17216-17221
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2116431617
- Cited by
- 328
- References
- 35
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.